Pteroic acid is a critical derivative of folic acid classified as an antifolate agent that functions by inhibiting dihydrofolate reductase to block folate metabolism, thereby interfering with DNA synthesis… Read more
Pteroic acid is a critical derivative of folic acid classified as an antifolate agent that functions by inhibiting dihydrofolate reductase to block folate metabolism, thereby interfering with DNA synthesis and cell division in rapidly dividing tissues for the treatment of specific cancers and autoimmune conditions. This category provides access to high-quality reference standards, including the active pharmaceutical ingredient itself, along with essential pharmacopeial impurities and metabolites such as 5-methyl-tetrahydropteroic acid. These compounds are vital for pharmaceutical laboratories conducting rigorous analytical testing, impurity profiling, and method validation. By utilizing these precise reference materials, researchers can ensure accurate quality control and regulatory compliance during the development and manufacturing of folic acid-related therapeutics. The inclusion of stable isotope labelled compounds and related derivative standards supports comprehensive investigations into metabolic pathways and drug stability.